Clinical Trials Directory

Trials / Completed

CompletedNCT00657475

Coronary Bypass and Artotic Leaflet Surgery : Heparin Low Dose vs Full Dose

A Prospective Study of Coronary Artery Bypass Graft and/or Aortic Valve Replacement With Conventional Versus Half Heparin Dose Under Closed and Coated Extra Corporeal Circulation System (MECC) - APPACHES Study.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
238 (actual)
Sponsor
University Hospital, Bordeaux · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to demonstrate superiority on postoperative bleeding from the use of a heparin half dose compared to a conventional dose, under mini-extra corporeal circulation, without increased risk to the patient.

Detailed description

Usually management of conventional extra corporeal circulation takes place under a loading heparin dose of 300 IU / kg to achieve an ACT (activating clotting time) target more than 400 seconds. This empirical approach based on patient weight date from the 1960's and does not take into account materials improvement and different individual sensitivities; several studies have demonstrated than a result at least as effective could be obtained with heparin lower doses, and without increasing thromboembolic morbid events for patients. Patients are randomly assigned into one of 2 groups one day before surgery. First group receive unfractionated heparin conventional dose during the MECC, second group receive half of the conventional dose. All surgery is performed by the same team and using same equipment. Regular blood tests are carried out before, during and after surgery. Blood loss, transfusion needs, rhythm disorders, stay duration in intensive care and total hospitalization length is finally reported. The follow-up period through the 30th postoperative day.

Conditions

Interventions

TypeNameDescription
DRUGHeparin Low DoseLoading heparin dose of 150 IU / kg to achieve an ACT (activating clotting time) target more than 240 seconds.
DRUGHeparin Full DoseLoading heparin dose of 300 IU / kg to achieve an ACT (activating clotting time) target more than 400 seconds.

Timeline

Start date
2008-06-01
Primary completion
2013-02-01
Completion
2013-03-01
First posted
2008-04-14
Last updated
2013-05-07

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00657475. Inclusion in this directory is not an endorsement.